HOME
 Acute Myelogenous
 Leukemia (AML)
 Other Leukemia Types
 (ALL / CLL / CML / HCL)
 Myelodysplastic Syndrome
 Symptoms and Diagnosis
 Leukemia Treatment Options
  • Chemotherapy
  • Blood Stem Cell Transplants
  • Radiation and Surgery
  • Chemo Side Effects
  • Clinical Trials Info
  • Coping with Leukemia
  • What to Ask Your Doctor
 Financial Assistance
 At Risk Jobs/Exposure
 Leukemia Resources
 Survivor's Story
 Leukemia News

 Search for information:
 
      Match:
any search words
all search words

Click Here for a Free
Information Packet

FOR MORE INFORMATION
Please call
1-800-923-6376

We will gladly answer your
questions and send a free
packet with additional
information on:

  • New treatment options
  • New clinical trials
  • Doctors
  • Hazardous jobs and products
  • Medical Financial Aid

 




 
Acute myelogenous leukemia picture

 Blood Cancer &
 Leukemia
Medical information about cancer

  Leukemia Cancer Information
Leukemia symptoms

Search for: Results per page:

Match: any search words all search words

Search results for: mds

86 results found.

9 pages of results.
11. AML Acute Myelogenous Leukemia News October 2004
... , including leukemia, would be possible. http://www.medindia.net [Therapy-related MDS/leukemia carrying dup(11) (q21q23) with MLL gene tandem duplication ...
Score: 36  -  5 Feb 2007  -  URL: http://www.leukemia-web.org/leukemia-cancer-news-0410.htm
12. Revlimid Effective for Low-Risk Myelodysplastic Syndromes
... lenalidomide, CC5013) appears to be effective treatment in patients with myelodysplastic syndromes. MDS is a disease in which the cells in a person's bone marrow are not functioning ...
Score: 36  -  26 Sep 2006  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0034.htm
13. Myelodysplastic (MDS) Syndrome and Leukemia After Autotransplantation for Lymphoma
... Leukemia Cancer News- Return to Menu Myelodysplastic (MDS) Syndrome and Leukemia After Autotransplantation for Lymphoma: a Multicenter Case-Control Study Diana Stripp, MD University of Pennsylvania ...
Score: 35  -  26 Sep 2006  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0044.htm
14. Drug Helps Patients at High Risk for Leukemia
... in their 70s or 80s is showing promise for the treatment of myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML) ...
Score: 32  -  26 Sep 2006  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0017.htm
15. Acute Myelogenous Leukemia - AML News for July 2004
... 2004 SuperGen Announces Publication of Phase II Studies of Dacogen(TM) in Advanced MDS Patients Friday July 9, 8:00 am ET Low-Dose Therapy Had Clinically Significant ...
Score: 30  -  5 Feb 2007  -  URL: http://www.leukemia-web.org/leukemia-cancer-news-0407.htm
16. Scientists here have claimed to have discovered a new means of detecting Leukemia
... two schedules of the C-RAF kinase inhibitor BAY 43-9006 in patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): A NCI Canada Clinical Trials Group ...
Score: 30  -  5 Feb 2007  -  URL: http://www.leukemia-web.org/leukemia-cancer-news-0411.htm
17. REVLIMID(lenalidomide) Study in Low and Intermediate-1 Risk Myelodysplastic Syndromes
... Association- 51% of Eligible Low and Intermediate-1 Risk Transfusion Dependent Myelodysplastic Syndromes (MDS) Patients Without Deletion 5q Chromosomal Abnormality Achieve Hematologic Improvement, with 33% Achieving ...
Score: 30  -  5 Feb 2007  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0103.htm
18. FDA Grants Priority Review for REVLIMID(R) NDA for Treatment of Low- and Intermediate- Risk MDS With Deletion 5q Chromosomal Abnormality
... for REVLIMID(R) NDA for Treatment of Low- and Intermediate- Risk MDS With Deletion 5q Chromosomal Abnormality SUMMIT, N.J., June 21 /PRNewswire-FirstCall/ ...
Score: 29  -  5 Feb 2007  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0108.htm
19. Teva to commercialize Gamida-Cell's Stem-Ex, stem-cell derived treatment for leukemia and lymphoma
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28  -  26 Sep 2006  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0029.htm
20. United Blood Services Issues Critical Appeal for Platelet Donors
... seeking approval to market REVLIMID as a treatment for transfusion-dependent patients with myelodysplastic syndromes (MDS) with a 5q deletion chromosomal abnormality. MDS is a malignant disorder of blood ...
Score: 28  -  26 Sep 2006  -  URL: http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0065.htm
Result Pages: << Previous 1 2 3 4 5 6 7 8 9 Next >>

Search powered by Zoom Search Engine

 

 

Google

To Obtain the Best Treatment Info & Financial Assistance contact us for a FREE INFORMATION PACKET which includes:

Cancer Hospital Locations
Clinical Trials
Hazardous Jobs/ Products 		New Treatment Options
Doctors
Financial Assistance

Fill out the form below or call 1-800-923-6376.

First Name
Last Name
Address
City
State
Zip

Phone

Email
   
Have you or a loved one been diagnosed or have:
   
Acute Myelogenous
Leukemia (AML)?
Yes  No
Myelodysplastic Syndrome (MDS)?
Yes  No
Aplastic Anemia?
Yes  No
Non-Hodgkin Lymphoma (NHL)?
Yes  No
Any other Leukemia
or Blood Disease?
( In the comment section below please state the diagnosis)
Yes  No
Did you or your loved one ever work around benzene?
Display At Risk Jobs / Exposure
Yes  No

How old is the patient?

 
   

Comment/
Info Request 

 

 

Site Map | Acute Myelogenous Leukemia